Novelix Pharmaceuticals share news and announcements
BSE: 536565Healthcare ServicesSmall Cap
Last close ₹59.54down ₹3.19 (5.09%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹62.73.
52-week range of traded prices to 23 Oct 2026
₹45.03Low, 23 Oct 2025₹92.00High, 16 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹170 Cr2,861st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 13 Aug 2026
- 46.7
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- 11.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- 8.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.09
- Volume, BSEVolume. Shares traded on the last trading day.
- 1,524
Novelix Pharmaceuticals share news and announcements
605 announcements, routine notices left out, newest first. Page 4 of 13.
Nov 2024
11 Nov · Board meeting
Meeting on 13 Nov 2024: quarterly results
Oct 2024
25 Oct · Meeting
21 Oct · Board meeting
7 Oct · Board meeting
Meeting on 21 Oct 2024: increase in authorised capital and issue of warrants
Sep 2024
27 Sep · Meeting
2 Sep · Board meeting
Aug 2024
23 Aug · Board meeting
Meeting on 2 Sep 202413 Aug · Post Offer Advertisement
Jul 2024
31 Jul · Board meeting
Meeting on 8 Aug 2024: quarterly results15 Jul · Offer Opening Public Announcement
11 Jul · Updates on Open Offer - Recommendations of Committee of Independent Directors ("IDC")
Jun 2024
25 Jun · Board meeting
May 2024
16 May · Board meeting
Meeting on 28 May 2024: audited results
Apr 2024
13 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Mar 2024
20 Mar · Draft Letter of Offer